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driving research locally at NHS institutions. Clinical studies 
afflict changes to practice, impacting clinical service. The 
initial enthusiasm from clinical staffs to embark on a project 
has to be balanced against the implications of resources, 
costs and other developments. There is no standardised 
method to assess the impact of research projects on clinical 
practice. Therefore, the aim of this project was to develop 
and implement a Radiotherapy Research Activity Assessment 
Tool (RAAT) to assess the feasibility of newly proposed 
research projects within clinical settings. 
Materials and Methods: A multi-step development method 
was used. The steps involved the principals of Quality 
Function Deployment (QFD). The consecutive steps involved 
developing a user friendly and replicable tool and would fit 
on one A4 page. The process involved multi-professionals and 
patients throughout the design process. The tool was 
preliminary tested on usability among 8 stakeholders on a 10-
point scale (1=poor; 10=very good). Agreement was 
correlated to the initial probability scoring of the 8 
stakeholders. 
Results: The RAAT was developed in an e-form available in 
Microsoft Excel. The tool included details such as project 
title, date ranges and approval tab. It also needed to include 
meeting columns of where the project should be presented, 
along with details such as scope, and benefits to the clinical 
setting. A probability rating was included giving an indication 
of project success or failure. Finally a column to project the 
recruitment level of trials and comment boxes for additional 
information were added.  
The tool scored an average of 7/10 for usability and so 
alterations were made. Agreement between stakeholders 
resulted in a significant correlation of p=0.01 (Pearson = 
899).  
 
Conclusions: In conclusion the RAAT seems to be feasible in 
clinical practice, and provide a framework to guide the 
decision making process of accepting a research project. The 
tool calls for further testing of usability and long term 
implications on all stakeholders. 
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Purpose/Objective: Radiation therapists are an integral part 
of the radiation oncology team and their roles and 
responsibilities are expanding to advanced levels within 
clinical, educational and research settings in some countries. 
However, despite this expansion there is the perception that 
research with a specific focus on the radiation therapist 
continues to be underrepresented in the radiation oncology 
literature. We performed a novel review to identify recent 
ESTRO conference abstracts with a focus on the radiation 
therapist in order to quantify, describe and identify possible 
trends in this important area of study. 
Materials and Methods: With the aid of a medical librarian 
and the ESTRO events Co-ordinator we identified all 
published abstracts from the proceedings of the ESTRO 
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General and Biennial meetings and forums from 2004 to 2014 
inclusive. Abstracts were individually reviewed and only 
those with the radiation therapist being the main focus of the 
abstract were selected. The abstracts were then categorized 
according to specific themes based on subject matter. 
Results: In total 14935 abstracts were reviewed and only 46 
(0.3%) had the radiation therapist as the main focus. The 
number of selected abstracts by year ranged from a low of 1 
in 2004 to a high of 24 in 2014, with those from 2013 and 
2014 combined representing 65% of all selected abstracts. 
The selected abstracts were classified into the following 
themes: education (21 of 46), clinical applications (12 of 46), 
role definition (8 of 46), workplace wellness (3 of 46), and 
quality of care (2 of 46). 
Conclusions: Although the roles and responsibilities of 
radiation therapists are expanding and therapists are being 
recognized for their knowledge and skills in radiation 
oncology and cancer care more broadly, our results suggest 
that this expansion has not been proportionally represented 
in the radiation oncology literature as only 0.3% of published 
abstracts had a main focus on the radiation therapist. 
Encouragingly, however, the number of abstracts has 
increased substantially during the past 10 years, with the last 
two years alone far exceeding the preceding years combined. 
As the profession of the radiation therapist evolves and offers 
more opportunities for advanced practice qualifications and 
graduate level education it is expected that research on 
radiation therapists will increase, and the themes of said 
research will become more diverse. 
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Purpose/Objective: SBRT is the standard of care for 
inoperable patients with early-stage lung cancer without 
lymph node involvement. Excellent local control rates have 
been reported in a large number of series. However, 
prescription doses and calculation algorithms vary to a great 
extent between studies, even if most teams prescribe on the 
D95 of the PTV. Type A algorithms are known to produce 
dosimetric discrepancies in heterogeneous tissues such as 
lungs. This study was performed to present a MC prescription 
dose for NSCLC adapted to lesion size and location and 
compare the clinical outcome of two cohorts of patients 
treated with a type A algorithm and standard prescription 
dose or the proposed MC protocols. 
Materials and Methods: All inoperable patients treated in our 
institution between August 2007 and April 2013 with SBRT for 
early-stage lung cancer were included. Treatment planning 
was performed with a type A algorithm (Ray Tracing, RT) 
with 3 fractions of 20 Gy for peripheral lesions and 60 Gy in 5 
fractions for central lesions prescribed to the PTV D95 until 
January 2011. A type B algorithm (Monte Carlo, MC) with 54 
Gy in 3 fractions for peripheral lesions with a diameter under 
30 mm, 60 Gy in 3 fractions for lesions with a diameter over 
30 mm and 55 Gy in 5 fractions for central lesions was used 
for patients treated after this date. All treatment plans were 
recalculated with both algorithms for this study. Spearman’s 
rank correlation coefficient was calculated for GTV and PTV. 
Local control, overall survival and toxicity were compared 
between the two groups  
Results: 205 patients with 214 lesions were included in the 
study. 121 lesions were treated with RT and 93 with MC. D50 
of the GTV calculated with MC was poorly correlated with the 
D95 of the PTV calculated with RT (r=0.116) for lesions with a 
diameter of 20 mm or less. For lesions larger than 20 mm, 
spearman correlation was higher (r=0.618), but still 
insufficient. Overall survival rates were 94% and 86% at one 
and two years respectively. Local control rates were 93% and 
79% at one and two years respectively. There was no 
significant difference between the two groups for overall 
survival (p=0.785) or local control (p=0.934). 56 patients 
(27%) presented a grade 1 lung fibrosis without clinical 
consequences. GTV size was a prognostic factor for overall 
survival (HR=1.026, IC95% [1.01-1.041], p<0.001) and total 
dose was a prognostic factor for local control (HR=0.924, 
IC95% [0.870-0.982], p=0.011). 
Conclusions: The dose calculated with a type A algorithm 
does not correctly reflect the dose actually received by the 
tumor. A type B algorithm should be preferred to directly 
prescribe on the GTV in order to avoid the dose calculation 
variability created by normal lung tissue found in the GTV to 
PTV margin. Patients treated with the proposed protocol had 
the same local control and overall survival rates as patients 
treated with the type A algorithm. 
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Purpose/Objective: We evaluated sequential magnetic 
resonance imagings to assess the inherent response of 
intracranial meningiomas after three-dimensional conformal 
radiation therapy. 
Materials and Methods 
Quantitative tumor volume measurements were generated 
from 126 magnetic resonance images of a total of 26 
patients. Both parametric and nonparametric regression 
analyses were used to assess the relationships of the 
percentage of tumor volume reduction with the elapsed time 
after irradiation and the pattern of tumor volume reduction. 
Results: The median follow-up time was 103.5 months 
(range, 29.6–137.3 months). The mean pre-radiation therapy 
tumor volume was 28.60 cm3 (range, 1.34–167.35 cm3). 
Tumor volume reduction was observed in 96.2% of the study 
population. The mean absolute and relative tumor volume 
reduction were 13.9 cm3 (range, 0.4–84.5 cm3) and 44.6% 
(range, 14.7–89.0%), respectively. After irradiation, the 
tumor volume reduction rate was 8.02% per year. 
Meningiomas that were ≥40 cm3 showed a higher rate of 
